Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Shock. 2008 Oct;30(4):434–442. doi: 10.1097/SHK.0b013e3181673543

Figure 2. Mortality following intraperitoneal LPS administration is reduced in GM-CSF deficient mice.

Figure 2

Wild-type (n=19) or GM-CSF−/− mice (n=20) received LPS by intraperitoneal injection and then mortality was evaluated every 12 hours over 7 days.